According to a report published by Grand View Research, Inc.; the orthobiologics market is expected to reach a valuation of around USD 10.2 billion by 2025.
Rise in prevalence of orthopedic disease and musculoskeletal disease across the world, growing number of orthopedic procedures due to accidence and obesity can propel the market during the forecast period (2014 to 2025). In addition, increasing geriatric population which are at high risk to spinal and other orthopedic disorders are also leading orthopedic surgeries.
Technological developments in biomaterials used in the manufacturing of orthobiologics are expected to accelerate the market growth in the coming years. These developments include modifications in graft designs, development of recombinant biologic agents, cultured tissue scaffolds, and stem cell therapy. These advancements can offer many benefits such as improved biocompatibility, smaller incisions, and reduction in surgical time. Moreover, these innovative solutions are assumed to efficiently decrease the repetition of post-operative complications. This is likely to spur the market growth in the coming years.
Worldwide orthobiologics market can be segmented on the basis of product, application, end-use, and region.
Full Research Report On Orthobiologics Market Analysis: https://www.grandviewresearch.com/industry-analysis/orthobiological-products-market
Orthobiologics market, by product, 2014 – 2025 (USD Billion)
As per product, the market can be segmented on the basis of demineralized bone matrix (DBM), allograft, bone morphogenetic protein (BMP), viscosupplementation, synthetic bone substitutes, and stem cell therapy.
The viscosupplementation segment held for the major share in 2015. This can be credited to high utilization of these products because of its availability and impressive use in complaints including hip degenerative joint disease and osteoarthritis. It offers several benefits such as pain reduction, less side-effects, minimum incision, better knee movement. Increasing popularity of minimally invasive surgeries are also expected to boost the segment in the coming years.
As per application, the market can be split into spinal fusion, trauma repair, and reconstructive surgery.
The spinal fusion segment estimated for the largest share over 50.0% in 2015. This can be attributed to high utilization of bone morphogenetic proteins, demineralized bone matrices, autografts and allografts in spinal fusion procedures due to its capability to provide better stability to bone and fast bone healing. This leads to improvement of long-term spinal disorders. Other benefits include fast stimulation of cells to provide bone formation and avoids frequent hospital stay and visits.
On the basis of end-use, the market can be classified into hospitals and orthopedic clinics.
View More Reports Of This Category By Grand View Research At: https://www.grandviewresearch.com/industry/biotechnology
Orthobiologics market share by region, 2015 (%)
The hospitals segment estimated for the largest share in 2015. This can be attributed to growing use of orthobiological products in different spinal and reconstructive surgeries, which are performed in the hospitals. In addition, convenience of specialized patient care and easy availability of widespread range of products in hospitals is considered as the crucial driving factors for the segment.
Geographically, the market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
In 2015, North America estimated for the largest market share due to the presence of key players which are involved in encouraging quality care and are taking responsibility for new product development strategies. Additionally, availability of better reimbursement policies for soft tissue healing and fusion improvement products are also supporting the regional growth.
Asia Pacific is likely to expand swiftly over the forecast period due to increasing healthcare expenditure, rise in disposable income, growing physician awareness levels about the benefits of these products. Rapid development in healthcare infrastructure is also expected to provide lucrative gains across the region in the coming years. In addition, growing product launch across the region is also driving the growth in this region.
Some of the leading companies operating in the market include DePuy Synthes, Inc.; Medtronic; Stryker Corporation; Genzyme; and Smith & Nephew plc.
Major companies are involved in new product development activities, mergers and acquisitions, collaborations and distribution improvement strategies, and frequent product approval to gain traction in the market. Players are also making high investments for R&D. Increasing collaboration between biotechnology companies and medical device companies to develop advanced orthobiologics is expected to support the market growth.
Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
Country: United States